Search - tctmd.com

Displaying 181 - 197 of 197

Sort: Relevancy | Date

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

March 25, 2012

News Daily News

African-Americans Have Higher Bleeding Rates After Reperfusion for STEMI

L.A. McKeown

March 20, 2012

News Daily News

Los Afroamericanos Tienen Índices de Hemorragia Más Altos tras la Reperfusión de un STEMI

L.A. McKeown

March 20, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

Análisis PLATO: Los IBP son Problemáticos tanto con el Ticagrelor como con el Clopidogrel

Caitlin E. Cox

March 06, 2012

Presentation

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events

Presenter: Michael V. Holmes

January 04, 2012

News Daily News

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

January 03, 2012

Presentation TCT 2012

Genetic Variants Affecting Clopidogrel Metabolism Have Minor Influence on Platelet Reactivity After Elective Percutaneous Coronary Intervention

Presenter: Andr?s Kom?csi, Orsolya Rideg, Gy?ngyv?r K?lt?, Andr?s Vorobcsuk, Daniel Aradi

January 03, 2012

Presentation

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events

Presenter: Michael V. Holmes

January 03, 2012

News Industry News

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

November 04, 2011

News Daily News

Genetic Predictors of Early Stent Thrombosis Identified

L.A. McKeown

October 25, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Daily News

High Homocysteine Levels Linked with Contrast Nephropathy

Jason Kahn

July 28, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Caitlin E. Cox

January 25, 2011

CME

Advertisement

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

African-Americans Have Higher Bleeding Rates After Reperfusion for STEMI

Los Afroamericanos Tienen Índices de Hemorragia Más Altos tras la Reperfusión de un STEMI

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Análisis PLATO: Los IBP son Problemáticos tanto con el Ticagrelor como con el Clopidogrel

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

Genetic Variants Affecting Clopidogrel Metabolism Have Minor Influence on Platelet Reactivity After Elective Percutaneous Coronary Intervention

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Genetic Predictors of Early Stent Thrombosis Identified

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

High Homocysteine Levels Linked with Contrast Nephropathy

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content